Company / AR per Share
Arrowhead Pharmaceuticals AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.05
FY2025
5-year range
$0.00 / $0.10
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#96 of 113
Health Care
What the data says
Arrowhead Pharmaceuticals's ar per share of $0.05 is lower than 85% of companies in the Health Care sector (FY2025). Improved from $0.00 to $0.05 over the past 2 years.
Based on SEC 10-K filings.
0.05 in FY2025 with a 5-year CAGR of +44.0%.
Improved from $0.00 to $0.05 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +59.5%
- 5-Year CAGR
- +44.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 113This company $0.05 Sector average $28.83
▼
-99.8% below sector average
Key checks
Key Insights
- Ranks #96 out of 113 companies in the Health Care sector.
- Peak ar per share was recorded in FY2021.
- Lowest ar per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.05 | - |
| FY2024 | $0.00 | - |
| FY2023 | $0.00 | -100.0% |
| FY2022 | $0.01 | -86.5% |
| FY2021 | $0.10 | +1030.8% |
| FY2020 | $0.01 | +18.5% |
| FY2019 | $0.01 | +70.7% |
| FY2018 | $0.00 | +350.3% |
| FY2017 | $0.00 | -22.8% |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026